The Life Sciences Accounting & Reporting Congress is the premier event for CFOs, Corporate Controllers, Finance and Accounting leaders navigating the intricate financial landscape of the unique life sciences industry.

Celebrating it's 22nd year in 2027, this event is the only event dedicated specifically to life sciences accounting and reporting, bringing together a thriving community of 350+ specialists dedicated to driving excellence in this field.

This congress goes beyond theory, delivering actionable insights through three specialized tracks tailored to different organizational needs and experience levels:

• Mid/Large Company Track
• Small/Emerging Company Track
• Operational Excellence

This hotly anticipated congress delivers comprehensive financial expertise and strategic accounting solutions essential for pharmaceutical cost accounting methodologies, financial reporting standards and regulatory compliance across global markets. Finance leaders will master navigating supply chain turbulence, implementing shared services solutions, and leveraging technology and automation, empowering attendees to maximize operational efficiency, strengthen financial controls, and drive sustainable value creation that supports long-term business objectives

The Life Sciences Accounting & Reporting Congress will be held on March 22-24, 2027, in Philadelphia, Pennsylvania.

You will benefit from attending the Life Sciences Accounting & Reporting Congress if you are a CFO, CAO, Controller or senior‑level director working in pharmaceutical, biotech and medical device companies, with responsibilities or involvement in the following areas:

• Accounting
• Financial Reporting
• Auditing
• Finance
• Financial Planning & Analysis
• Revenue
• Forecasting
• Transactions
• Risk and Controls
• Contracts
• Business/Corporate Development
• Business Decision Support

This conference will also benefit consultants, software providers and auditing firms that provide outside council to pharmaceutical accounting executives.

Yes, you can register you interest in attending to be the first to hear about registration savings when registration becomes available.

The Life Sciences Accounting & Reporting Congress covers a comprehensive range of topics including:

• AI and digital transformation in life sciences finance
• ESG reporting and sustainability disclosure requirements
• SEC and FASB regulatory updates and compliance
• Inflation Reduction Act (IRA) financial impact and compliance
• Revenue recognition and GTN (Gross-to-Net) methodologies
• Clinical trial financial management and accounting
• Supply chain financial strategies and risk management
• Clinical-to-commercial transition accounting
• Internal audit and SOX compliance excellence
• Strategic capital deployment and M&A frameworks
• Accounting and reporting for small and large pharmaceutical, biotech and medical device manufacturers
• Chief Finance Officer (CFO) leadership

The event is an in-person conference taking place over three days:

• March 22, 2027: Conference Day 1
• March 23, 2027: Conference Day 2
• March 24, 2027: Conference Day 3

Yes, the Congress brings together 350+ accounting, reporting and finance professionals from across the life sciences sector, providing an excellent opportunity for networking. The agenda includes round table discussions specifically designed for exchanging insights, exploring opportunities and connecting with like-minded professionals.

Yes, this congress is specifically structured to serve emerging biotech companies navigating their first commercial launches, as well as growing mid-sized medical device manufacturers and established pharmaceutical organizations managing complex global operations. The program features comprehensive sessions on regulatory compliance, advanced accounting methodologies, and technology solutions to support financial excellence.

It also features dedicated tracks tailored to companies at different stages of growth.

The Small/Emerging Pharma Track addresses the critical needs of developing companies with sessions on Enterprise Resource Planning (ERP) implementation and automation, clinical trial accounting best practices, valuation complexities for early-stage assets, and an exclusive industry-only forum for emerging biotech financial leaders to share strategies and challenges.

The Mid to Large Pharma Track focuses on ensuring robust financial management capabilities on a larger scale, including finance data strategy and AI integration, internal audit frameworks for strengthening financial controls, strategic financial disclosures and segment reporting, plus a young professionals roundtable supporting career development in this invaluable field.

The congress is organized by Informa Connect, part of Informa PLC. View more of our biotech and pharma events here.

The detailed 2026 agenda is available to view here and to download below:

Yes. At the 2026 Congress attendees could earn up to 20.4 group live (in person attendance) credits. Get full details on our CPE credits page here.